{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T08:27:54Z","timestamp":1786523274125,"version":"build-2736575974"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100031550","name":"Oral Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031550","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018047","name":"NRG Oncology Foundation Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018047","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ijrobp.2026.02.242","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T23:47:18Z","timestamp":1773272838000},"page":"118-133","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Quality of Life in Patients With p16+ Oropharyngeal Cancer Receiving Accelerated Radiation Therapy With Either Cisplatin or Cetuximab in the NRG\/RTOG 1016 Randomized Controlled Trial"],"prefix":"10.1016","volume":"126","author":[{"given":"Jolie","family":"Ringash","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro A.","family":"Torres-Saavedra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura L.","family":"Gillison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimmy J.","family":"Caudell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Adelstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Harari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erich M.","family":"Sturgis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan","family":"Basch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shlomo A.","family":"Koyfman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg A.","family":"Krempl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dukagjin M.","family":"Blakaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James Edward","family":"Bates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Galloway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher U.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth M.","family":"Beadle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quynh-Thu","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue S.","family":"Yom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Movsas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2026.02.242_bib0001","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1053\/j.seminoncol.2004.09.011","article-title":"Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity","volume":"31","author":"Gillison","year":"2004","journal-title":"Semin Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.242_bib0002","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer","volume":"363","author":"Ang","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2026.02.242_bib0003","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S1470-2045(15)00560-4","article-title":"Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): A multicentre cohort study","volume":"17","author":"O'Sullivan","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.242_bib0004","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.ijrobp.2006.06.013","article-title":"Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: Initial report on a randomized controlled clinical trial","volume":"66","author":"Pow","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.02.242_bib0005","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.oraloncology.2013.02.013","article-title":"Quality-of-life outcomes in patients with head and neck squamous cell carcinoma (HNSCC) treated with intensity-modulated radiation therapy (IMRT) compared to three-dimensional conformal radiotherapy (3D-CRT): Evidence from a prospective randomized trial","volume":"49","author":"Rathod","year":"2013","journal-title":"Oral Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.242_bib0006","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1470-2045(10)70290-4","article-title":"Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): A phase 3 multicentre randomised controlled trial","volume":"12","author":"Nutting","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.242_bib0007","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa053422","article-title":"Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck","volume":"354","author":"Bonner","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2026.02.242_bib0008","unstructured":"Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, eds. AJCC Cancer Staging Manual. 7th ed. Springer; 2010."},{"key":"10.1016\/j.ijrobp.2026.02.242_bib0009","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/PAS.0b013e318253a2d1","article-title":"Validation of methods for oropharyngeal cancer HPV status determination in US cooperative group trials","volume":"36","author":"Jordan","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ijrobp.2026.02.242_bib0010","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(18)32779-X","article-title":"Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): A randomised, multicentre, non-inferiority trial","volume":"393","author":"Gillison","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2026.02.242_bib0011","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1200\/JCO.2006.08.8005","article-title":"Quality of life in head and neck cancer patients after treatment with high-dose radiotherapy alone or in combination with cetuximab","volume":"25","author":"Curran","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.242_bib0012","series-title":"Effect of Cancer on Quality of Life","first-page":"185","article-title":"The EORTC core quality-of-life questionnaire: Interim results of an international field study","author":"Aaronson","year":"1991"},{"key":"10.1016\/j.ijrobp.2026.02.242_bib0013","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1200\/JCO.1999.17.3.1008","article-title":"Quality of life in head and neck cancer patients: Validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35","volume":"17","author":"Bjordal","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.242_bib0014","unstructured":"EORTC. Questionnaires. https:\/\/qol.eortc.org\/questionnaires. Accessed September 25, 2023."},{"key":"10.1016\/j.ijrobp.2026.02.242_bib0015","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/(SICI)1097-0215(1999)83:12+<132::AID-IJC23>3.0.CO;2-4","article-title":"Interpreting the meaningfulness of changes in health-related quality of life scores: Lessons from studies in adults","volume":"12","author":"Osoba","year":"1999","journal-title":"Int J Cancer Suppl"},{"key":"10.1016\/j.ijrobp.2026.02.242_bib0016","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1214\/aos\/1013699998","article-title":"The control of the false discovery rate in multiple testing under dependency","volume":"29","author":"Benjamini","year":"2001","journal-title":"Ann Statist"},{"key":"10.1016\/j.ijrobp.2026.02.242_bib0017","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1080\/01621459.1980.10477552","article-title":"Pairwise multiple comparisons in the unequal variance case","volume":"75","author":"Dunnett","year":"1980","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.ijrobp.2026.02.242_bib0018","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.ijrobp.2016.03.017","article-title":"Effect of p16 status on the quality of life experience during chemoradiation for locally advanced oropharyngeal cancer: A sub-study of randomized trial Trans-Tasman Radiation Oncology Group (TROG) 02.02 (HeadSTART)","volume":"97","author":"Ringash","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.02.242_bib0019","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ejca.2016.11.008","article-title":"Quality of life and swallowing with standard chemoradiotherapy versus accelerated radiotherapy and panitumumab in locoregionally advanced carcinoma of the head and neck: A phase III randomised trial from the Canadian Cancer Trials Group (HN.6)","volume":"72","author":"Ringash","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2026.02.242_bib0020","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.ijrobp.2023.02.041","article-title":"Patient-reported symptom severity, health-related quality of life and emotional distress trajectories during and after radiation therapy for human papillomavirus-associated oropharyngeal cancer: A TROG 12.01 secondary analysis","volume":"116","author":"McDowell","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.02.242_bib0021","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2021.2907","article-title":"Projected association of human papillomavirus vaccination with oropharynx cancer incidence in the US, 2020-2045","volume":"7","author":"Zhang","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.242_bib0022","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.ijrobp.2021.07.1693","article-title":"Have we tipped the balance in HPV-associated oropharyngeal cancer?: The patient-experience side of the de-escalation balance scale","volume":"111","author":"Ringash","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.02.242_bib0023","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/S0277-9536(99)00045-3","article-title":"Integrating response shift into health-related quality of life research: A theoretical model","volume":"48","author":"Sprangers","year":"1999","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.ijrobp.2026.02.242_bib0024","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/bjc.1991.296","article-title":"Assessment of quality of life in small-cell lung cancer using a Daily Diary Card developed by the Medical Research Council Lung Cancer Working Party","volume":"64","author":"Fayers","year":"1991","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijrobp.2026.02.242_bib0025","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/S1470-2045(23)00265-6","article-title":"Dysphagia-optimised intensity-modulated radiotherapy versus standard intensity-modulated radiotherapy in patients with head and neck cancer (DARS): A phase 3, multicentre, randomized, controlled trial","volume":"24","author":"Nutting","year":"2023","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.242_bib0026","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.ijrobp.2016.12.033","article-title":"Quality of life in head and neck cancer: Where we are, and where we are going","volume":"97","author":"Ringash","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.02.242_bib0027","unstructured":"EORTC. Head & neck cancer (update of QLQ-H&N35). https:\/\/qol.eortc.org\/questionnaire\/qlq-hn43\/. Accessed September 25, 2023."},{"key":"10.1016\/j.ijrobp.2026.02.242_bib0028","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/hed.25609","article-title":"International validation of the revised European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module, the EORTC QLQ-HN43: Phase IV","volume":"41","author":"Singer","year":"2019","journal-title":"Head Neck"},{"key":"10.1016\/j.ijrobp.2026.02.242_bib0029","first-page":"10","article-title":"Clinical trials need more diversity","volume":"319","year":"2018","journal-title":"Scientific American"},{"key":"10.1016\/j.ijrobp.2026.02.242_bib0030","article-title":"Race\/ethnicity reporting and representation in US clinical trials: A cohort study","volume":"11","author":"Turner","year":"2022","journal-title":"Lancet Reg Health Am"},{"key":"10.1016\/j.ijrobp.2026.02.242_bib0031","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1200\/JCO.19.00370","article-title":"Evolution of the oropharynx cancer epidemic in the United States: Moderation of increasing incidence in younger individuals and shift in the burden to older individuals","volume":"37","author":"Tota","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.242_bib0032","doi-asserted-by":"crossref","first-page":"4","DOI":"10.21037\/ace-22-1","article-title":"Racial\/ethnic disparities in HPV-related oropharyngeal cancer outcomes among males in the United States: A national cohort study","volume":"6","author":"Villalona","year":"2022","journal-title":"Ann Cancer Epidemiol"},{"key":"10.1016\/j.ijrobp.2026.02.242_bib0033","first-page":"2463","article-title":"Predictors of quality of life in head and neck cancer survivors up to 5 years after end of treatment: A cross-sectional survey","volume":"24","author":"Wells","year":"2016","journal-title":"Support Care Cancer"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301626004359?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301626004359?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T07:35:50Z","timestamp":1786520150000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301626004359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0360301626004359"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2026.02.242","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quality of Life in Patients With p16+ Oropharyngeal Cancer Receiving Accelerated Radiation Therapy With Either Cisplatin or Cetuximab in the NRG\/RTOG 1016 Randomized Controlled Trial","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2026.02.242","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}